Clinical and regulatory intelligence for Crohn's Disease with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Assets: 1

Relevant assets

Phase →

Relevant companies

No related entities indexed yet.

Recent signals(1)

ClinicalJuly 4, 2026

Phase II Trial Comparing IOUS-Guided Margin Selection in Crohn's Disease Surgery

A Phase II trial is underway to compare intraoperative ultrasound (IOUS)-guided margin selection with standard methods in ileocolic resection for terminal ileal Crohn's disease.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Crohn's Disease →

Gastroenterology →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.